|
|
Line 12: |
Line 12: |
| | | |
| | | |
− | <a href="https://static.igem.org/mediawiki/2015/d/dd/ATOMS-Turkiye_reeesim.png" data-lightbox="image-1"><img src="https://static.igem.org/mediawiki/2015/d/dd/ATOMS-Turkiye_reeesim.png" width="900" height="750"></a> | + | <a href="https://static.igem.org/mediawiki/2015/d/dd/ATOMS-Turkiye_reeesim.png" data-lightbox="image-1"><img src="https://static.igem.org/mediawiki/2015/d/dd/ATOMS-Turkiye_reeesim.png" width="900" height="650"></a> |
| | | |
| | | |
Line 21: |
Line 21: |
| | | |
| <br> | | <br> |
| + | <p> |
| | | |
− | <p>Have created a system which aims to treat gastric ulcer and gastric cancer.</p>
| + | 1.Have created a system which aims to treat gastric ulcer and gastric cancer. |
| | | |
− | <p>Designed new biobricks such as Toehold switch, Dam-Pexiganan, GadE, POTB59, Trigger
| + | 2. Designed new biobricks such as Toehold switch, Dam-Pexiganan, GadE, POTB59, Trigger RNA... |
| | | |
− | RNA...</p> | + | 3. Successfully worked our Toehold switch-Trigger RNA system, GadE, POTB59, HNS parts. We increased the rate of mRNA level protein expression with Toehold switch-Trigger RNA system, had E. Coli more acid resistant by overexpressing GadE, and speeded up the bacteria with HNS and PotB59 parts. |
| | | |
− | <p>Successfully worked our Toehold switch-Trigger RNA system, GadE, POTB59, HNS parts. We
| + | 4. Have created a new vector for co-transformation which named pColA. |
| | | |
− | increased the rate of mRNA level protein expression with Toehold switch-Trigger RNA
| + | 5. Have combined pSB1C3 plasmid with T7 promoter in order to increase protein expression. |
| | | |
− | system, had E. Coli more acid resistant by overexpressing GadE, and speeded up the bacteria
| + | 6. Mentored AUC TURKEY high school team. |
| | | |
− | with HNS and PotB59 parts.</p> | + | 7. Offered a very new approach to synthetic biology and medicne; Virtual Hospital. Designed a futuristic hospital with our new diagnosis&treatment methods in synthetic biology.Evaluated feasibility of synthetic biology on today’s and tomorrow’s medical applications.</p> |
| | | |
− | <p> Have created a new vector for co-transformation which named pColA. </p>
| + | 8. Have criticized our project approach in terms of treatment management and monitoring our safety and security! Several researches have been conducted about the-state-of-art clinical practice and methods to compare the new and old features. |
− | | + | |
− | <p>Have combined pSB1C3 plasmid with T7 promoter in order to increase protein expression.</p>
| + | |
− | | + | |
− | <p> Mentored AUC TURKEY high school team.</p>
| + | |
− | | + | |
− | <p>Offered a very new approach to synthetic biology and medicne; Virtual Hospital. Designed a
| + | |
− | | + | |
− | futuristic hospital with our new diagnosis&treatment methods in synthetic biology.
| + | |
− | | + | |
− | Evaluated feasibility of synthetic biology on today’s and tomorrow’s medical applications.</p>
| + | |
− | | + | |
− | <p>Have criticized our project approach in terms of treatment management and monitoring our
| + | |
− | | + | |
− | safety and security! Several researches have been conducted about the-state-of-art clinical | + | |
− | | + | |
− | practice and methods to compare the new and old features. | + | |
| </p> | | </p> |
| | | |